Pfizer said Thursday it completed a $43 billion takeover of cancer-focused biotech company Seagen that the pharma giant said would enable it to double its oncology platform.
Dec 14, 2023
0
0
A new American Cancer Society study puts a price tag on racial disparities in cancer mortality, finding that $3.2 billion in lost earnings would have been avoided in 2015 if non-Hispanic (NH) blacks had equal years of life ...
Jun 3, 2020
0
0
A research study from Queen's University Belfast, in collaboration with University College Dublin, University College London and Cass Business School, has found that babies who were breastfed went on to have a higher household ...
Oct 15, 2018
0
1
Eli Lilly raised its 2019 forecast after a jump in sales from the diabetes treatment Trulicity helped push the drugmaker to a better-than-expected second quarter.
Jul 30, 2019
0
0
Mental disorders that emerge in childhood and adolescence, including attention-deficit disorder, depression, anxiety and substance abuse, constitute significant challenges to cognitive, emotional, and social development. ...
Jul 31, 2012
0
0
French drugmaker Sanofi sacked its CEO Wednesday following a board room rift over his way of handling one of France's largest publicly traded companies.
Oct 29, 2014
0
0
(HealthDay)—The incomes of U.S. doctors have grown less than the incomes of other health professionals over the past few decades, a new study indicates.
Nov 27, 2012
0
0
Pfizer Inc., finally turning the corner after years of generic competition that slashed revenue from the drugmaker's former blockbusters, easily beat Wall Street expectations for the third quarter and raised its 2015 earnings ...
Oct 27, 2015
0
3
British drugmaker GlaxoSmithKline said Wednesday that third-quarter net profits fell 18.5 percent from a year earlier to £1.12 billion ($1.80 billion, 1.39 billion euros), hit by weak conditions in Europe.
Nov 1, 2012
0
0
US generic drugs specialist Mylan said Thursday it would buy a unit of India's pharma firm Strides Arcolab for $1.6 billion, boosting its presence in the high-growth injectable drugs market.
Feb 27, 2013
0
0
